Company news

Alteogen Inc. news in 2025

Alteogen Inc.'s news releases, calls and decks from 2025, newest first.

Alteogen Receives European Commission Approval for Aflibercept Biosimilar, EYLUXVI® (ALT-L9)

September 17, 2025

Alteogen Receives Positive CHMP Opinion for Aflibercept Biosimilar, 'EYLUXVI® (ALT-L9)'

July 28, 2025

Decks in 2025

Korea Investment Week 2025
Conference · 27 slides · Sep 17, 2025